12 Facts About Sun Pharma


Sun Pharma was listed on the stock exchange in 1994 in an issue oversubscribed 55 times.

FactSnippet No. 1,089,835

Sun Pharma has complemented growth with select acquisitions over the last two decades.

FactSnippet No. 1,089,836

In 1996, Sun purchased a bulk drug manufacturing plant at Ahmednagar from Knoll Pharmaceuticals and MJ Pharma's dosage plant at Halol that are both U S FDA approved today.

FactSnippet No. 1,089,837

In 1997, Sun Pharma acquired Tamil Nadu Dadha Pharmaceuticals Limited based in Chennai, mainly for their extensive gynaecology and oncology brands.

FactSnippet No. 1,089,838

Also in 1997, Sun Pharma initiated their first foray into the lucrative US market with the acquisition of Caraco Pharmaceuticals, based in Detroit.

FactSnippet No. 1,089,839

In 1998, Sun acquired a number of respiratory brands from Natco Pharma.

FactSnippet No. 1,089,840

In 2011, Sun Pharma entered into a joint venture with MSD to bring complex or differentiated generics to emerging markets .

FactSnippet No. 1,089,841

On 6 April 2014, Sun Pharma acquired Ranbaxy in a US$4 billion landmark transaction to create the world's 5th largest specialty generic pharmaceutical company.

FactSnippet No. 1,089,842

In March 2015, Sun Pharma announced it had agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

FactSnippet No. 1,089,843

In 2019, Sun Pharma acquired Pola Pharma in Japan to strengthen its global dermatology presence.

FactSnippet No. 1,089,844

Sun Pharma entered the Greater China market by partnering with China Medical System Holdings as well as launched a speciality product, Cequa, in the United States for the treatment of dry eyes.

FactSnippet No. 1,089,845

Sun Pharma stood second in the India's Most Reputed Brands list in a study conducted by BlueBytes, a leading Media Analytics firm in association with TRA Research, a brand insights organization .

FactSnippet No. 1,089,846